Celcuity Raises $24M Via Upsized Equity Offering At 11% Discount


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


  • Celcuity Inc (NASDAQ: CELC) has priced its upsized underwritten public offering of 1.7 million shares at $14 per share, raising approximately $24 million in gross proceeds. The offer price is at an 11% discount from the last close price of $15.7 on Tuesday.
  • Previously the company had announced the offering of $20 million.
  • The underwriter has an option to purchase up to an additional 257,100 shares, and the offering will close by February 26.
  • Celcuity intends to use the proceeds for working capital and general corporate purposes.
  • Craig-Hallum Capital Group is acting as the sole managing underwriter for the offering.
  • In January, the company announced a clinical trial collaboration with Sarah Cannon Research Institute and Pfizer Inc to conduct a Phase 2 clinical trial. 
  • The trial will evaluate the efficacy and safety of two Pfizer targeted therapies VIZIMPRO and XALKORI, in patients with previously treated metastatic HER2-negative breast cancer selected with Celcuity's CELsignia Multi-Pathway Activity Test.
  • In December, Celcuity announced a trial collaboration with Massachusetts General Hospital, UCLA, and Vanderbilt and Puma Biotechnology to conduct a Phase 2 trial.
  • The company expects to announce additional trial collaborations in the first half of 2021.
  • Celcuity ended the fourth quarter with cash and cash equivalents of $11.6 million.
  • Price Action: CELC stock is down 7.76% at $14.50 in market trading hours on the last check Wednesday.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsHealth CareOfferingsGeneral